These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7832899)

  • 1. Transgenic-mouse model of amyotrophic lateral sclerosis.
    Gurney ME
    N Engl J Med; 1994 Dec; 331(25):1721-2. PubMed ID: 7832899
    [No Abstract]   [Full Text] [Related]  

  • 2. A transgenic-mouse model of amyotrophic lateral sclerosis.
    Brown RH
    N Engl J Med; 1994 Oct; 331(16):1091-2. PubMed ID: 8090173
    [No Abstract]   [Full Text] [Related]  

  • 3. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
    Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis.
    Kirkinezos IG; Hernandez D; Bradley WG; Moraes CT
    Ann Neurol; 2003 Jun; 53(6):804-7. PubMed ID: 12783429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is prostaglandin E(2) a pathogenic factor in amyotrophic lateral sclerosis?
    Almer G; Kikuchi H; Teismann P; Przedborski S
    Ann Neurol; 2006 Jun; 59(6):980-3. PubMed ID: 16619237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of amyotrophic lateral sclerosis.
    Mitsumoto H; Pioro EP
    Adv Neurol; 1995; 68():73-87; discussion 89-91. PubMed ID: 8787246
    [No Abstract]   [Full Text] [Related]  

  • 8. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
    Chritin M; Savasta M; Besson G
    Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of environmental enrichment on the amyotrophic lateral sclerosis mouse model.
    Sorrells AD; Corcoran-Gomez K; Eckert KA; Fahey AG; Hoots BL; Charleston LB; Charleston JS; Roberts CR; Markowitz H
    Lab Anim; 2009 Apr; 43(2):182-90. PubMed ID: 19246505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials.
    Rothstein JD
    Ann Neurol; 2003 Apr; 53(4):423-6. PubMed ID: 12666108
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
    Zhang J; Ito H; Wate R; Ohnishi S; Nakano S; Kusaka H
    Acta Neuropathol; 2006 Dec; 112(6):673-80. PubMed ID: 16957927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
    Morrison BM; Morrison JH; Gordon JW
    J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle in amyotrophic lateral sclerosis: emerging concepts and therapeutic implications.
    Abmayr S; Weydt P
    Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):1091-7, xi-xii. PubMed ID: 16214062
    [No Abstract]   [Full Text] [Related]  

  • 14. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
    Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
    Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Reinholz MM; Merkle CM; Poduslo JF
    Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroacupuncture reduces neuroinflammatory responses in symptomatic amyotrophic lateral sclerosis model.
    Yang EJ; Jiang JH; Lee SM; Hwang HS; Lee MS; Choi SM
    J Neuroimmunol; 2010 Jun; 223(1-2):84-91. PubMed ID: 20460191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ALS models by transgenic animals].
    Aoki M; Nagai M; Kato M; Itoyama Y
    No To Shinkei; 2001 Sep; 53(9):799-807. PubMed ID: 11596474
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis.
    Parkhouse WS; Cunningham L; McFee I; Miller JM; Whitney D; Pelech SL; Krieger C
    Amyotroph Lateral Scler; 2008; 9(1):24-34. PubMed ID: 18273716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Regulatory T Lymphocytes in Amyotrophic Lateral Sclerosis.
    Beers DR; Zhao W; Appel SH
    JAMA Neurol; 2018 Jun; 75(6):656-658. PubMed ID: 29507936
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modeling of lateral amyotrophic sclerosis: a transgenic method].
    Bachurin SO; Ninkina NN; Tarasova TV; Shelkovnikova TV; Kovrazhkina EA; Smirnov AP; Razinskaia OD; Skvortsova VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10):74-9. PubMed ID: 24404652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.